The PACS and RIS market in Europe is expected to grow from US$ 779.0 million in 2019 to US$ 1,439.9 million by 2027; it is estimated to grow at a CAGR of 7.9% from 2020 to 2027.
The national rate for CT scans were 126 per 1,000 individuals around 2014 and 2015. Rates ranged from 209 (New Brunswick) and 170 (Newfoundland and Labrador) to 88 (Alberta) and 93 (Prince Edward Island). In addition, according to the National Health Services (NHS) UK, there were 4.1 million imaging tests conducted in England in the 12 months from February 2017 to January 2017. Of these, 3.49 million imaging tests were reported to have taken place in January 2017. Moreover, as per the World Health Organization (WHO), with improved health care policy and the guided protocol of medical imaging for COVID-19 diagnosis, there has been a rise in the number of imaging-based procedures. Thus, the growing number of diagnostic imaging procedures performed across the region resulting in the increasing requirement of consumables for tests are likely expected to drive the growth of the Europe PACS and RIS market over the coming years.
The rapid spread of the COVID-19 virus and the special care that critical patients need put a major pressure on the European healthcare system. Government of various European countries started employing plans to prepare for the crisis situation after the boom of infections hit Italy in April 2020. During the action plan, the private and public healthcare institutions raised demand for radiological imaging devices of high quality to provide accurate diagnostics to the sufferers. The hospital capacities were increased in various countries for immediate treatment of the patients. The NHS also closely monitoring supplies of various medical devices in various countries of the region and managed distribution networks to make the primary equipment available to hospitals and public healthcare centers. Thus, the efforts undertaken by government created a surge in demand for PACS and RISs during the pandemic in the European region.
With the new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the PACS and RIS market. The Europe PACS and RIS market is expected to grow at a good CAGR during the forecast period.
Europe PACS and RIS Market Segmentation
By Product
By Component
By Deployment
By End User
By Country
Companies Mentioned
| Report Attribute | Details |
|---|---|
| Market size in 2019 | US$ 779.0 Million |
| Market Size by 2027 | US$ 1,439.9 Million |
| CAGR (2020 - 2027) | 7.9% |
| Historical Data | 2017-2018 |
| Forecast period | 2020-2027 |
| Segments Covered |
By Product
|
| Regions and Countries Covered |
Europe
|
| Market leaders and key company profiles |
|
The Europe PACS and RIS Market is valued at US$ 779.0 Million in 2019, it is projected to reach US$ 1,439.9 Million by 2027.
As per our report Europe PACS and RIS Market, the market size is valued at US$ 779.0 Million in 2019, projecting it to reach US$ 1,439.9 Million by 2027. This translates to a CAGR of approximately 7.9% during the forecast period.
The Europe PACS and RIS Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Europe PACS and RIS Market report:
The Europe PACS and RIS Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The Europe PACS and RIS Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the Europe PACS and RIS Market value chain can benefit from the information contained in a comprehensive market report.
Please tell us your area of interest
(Market Segments/ Regions and Countries/ Companies)
E 1803, Panchshil Towers,
Wagholi, Haveli,
Pune - 412207,
Maharashtra, India
US:+16467917070
sales@businessmarketinsights.com
Get Free Sample For Europe PACS and RIS Market
